Penumbra receives FDA clearance for stroke thrombectomy device
Go back to Penumbra receives FDA clearance for stroke thrombectomy device| (NYSE: PEN) | Delayed: 317.41 +1.21 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $316.20 | 52 Week High | $79.49 | |||
| Open | $317.39 | 52 Week Low | $40.23 | |||
| Day High | $318.46 | P/E | N/A | |||
| Day Low | $316.60 | EPS | $0.00 | |||
| Volume | 6,270 | |||||

